Evidence map›Paper›PMID 35513721›Full record

ArticleNature genetics2022

Prioritization of autoimmune disease-associated genetic variants that perturb regulatory element activity in T cells.

Kousuke Mouri, Michael H Guo, Carl G de Boer, Michelle M Lissner, Ingrid A Harten, Gregory A Newby, Hannah A DeBerg, Winona F Platt, Matteo Gentili, David R Liu and 4 more

Abstract read
In one paragraph

Article in Nature genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Genome-scale perturbation signatures from primary human CD4bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. HERV-K TM Subunit Elicits CD8Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  12. Article
  13. Review
  14. Article
  15. Expanding the DNA Motif Lexicon of the Transcriptional Regulatory Code.bioRxiv : the preprint server for biology · 2025
    Article
  16. Article
  17. Update on the genetics of allergic diseases.The Journal of allergy and clinical immunology · 2025
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Kousuke Mouri *The Jackson Laboratory, Bar Harbor, ME, USA.ORCID http://orcid.org/0000-0003-1712-6833
Michael H Guo *Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Carl G de BoerBroad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID http://orcid.org/0000-0001-8935-5921
Michelle M LissnerFundamental Immunology, Benaroya Research Institute, Seattle, WA, USA.
Ingrid A HartenSystems Immunology, Benaroya Research Institute, Seattle, WA, USA.
Gregory A NewbyBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Hannah A DeBergSystems Immunology, Benaroya Research Institute, Seattle, WA, USA.
Winona F PlattSystems Immunology, Benaroya Research Institute, Seattle, WA, USA.
Matteo GentiliBroad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-6970-8133
David R LiuBroad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-9943-7557
Daniel J CampbellFundamental Immunology, Benaroya Research Institute, Seattle, WA, USA.
Nir HacohenBroad Institute of MIT and Harvard, Cambridge, MA, USA. nhacohen@mgh.harvard.edu.ORCID http://orcid.org/0000-0002-2349-2656
Ryan TewheyThe Jackson Laboratory, Bar Harbor, ME, USA. ryan.tewhey@jax.org.ORCID http://orcid.org/0000-0002-4607-8001
John P RayBroad Institute of MIT and Harvard, Cambridge, MA, USA. jray@benaroyaresearch.org.ORCID http://orcid.org/0000-0001-7294-4260

Funding

Center for Genomic Editing and Recording: Development and Application of Next-Generation Genome and Epigenome Editing Methods to Advance the Study and Treatment of Human DiseaseRM1HG009490 · NHGRI · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI Brittany S. Adamson, Martin Joseph Ankrah Aryee · 2017 to 2026
$22.7M
Center for Cell CircuitsP50HG006193 · NHGRI · BROAD INSTITUTE, INC. · PI REGEV, AVIV · 2011 to 2015
$15.6M
Comprehensive functional characterization and dissection of noncoding regulatory elements and human genetic variationUM1HG009435 · NHGRI · BROAD INSTITUTE, INC. · PI SABETI, PARDIS CHRISTINE · 2017 to 2021
$6.6M
RESEARCH TRAINING IN RHEUMATOLOGYT32AR007108 · NIAMS · UNIVERSITY OF WASHINGTON · PI Shaun Jackson, Tomas M Mustelin · 1986 to 2026
$6.6M
Research Training Program in Disease Oriented Neuroscience (R25)R25NS065745 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI DETRE, JOHN A · 2009 to 2023
$3.0M
Biophysical and functional characterization of immune-related regulatory elements and noncoding variantsR01AI151051 · NIAID · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI SIGGERS, TREVOR · 2020 to 2024
$2.8M
Investigating Genetic and Epigenetic Control of T Cell Function in AutoimmunityDP2AI183504 · NIAID · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI John Philip Ray · 2023 to 2026
$2.6M
Non-coding genetic variants that impact immune phenotypes and diseasesR01HG008131 · NHGRI · BROAD INSTITUTE, INC. · PI HACOHEN, NIR · 2015 to 2017
$2.6M
Functional Mapping of Enhancer Conservation Between Species to Enable Mechanistic Insights into Polygenic DiseaseR35HG011329 · NHGRI · JACKSON LABORATORY · PI TEWHEY, RYAN · 2021 to 2025
$2.6M
Control of CD8+ T cell activation and differentiation by the signaling adaptor BCAPR01AI124693 · NIAID · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI CAMPBELL, DANIEL J, HAMERMAN, JESSICA A · 2016 to 2020
$2.6M
Expanding the Scope of Base EditingU01AI142756 · NIAID · BROAD INSTITUTE, INC. · PI LIU, DAVID R · 2018 to 2022
$2.1M
Massively Parallel Phenotypic Characterization of Non-coding Genetic VariationR00HG008179 · NHGRI · JACKSON LABORATORY · PI TEWHEY, RYAN · 2018 to 2020
$747k
Howard Hughes Medical InstituteNHGRI NIH HHS K99 HG009920NHGRI NIH HHS P50 HG006193NHGRI NIH HHS R00 HG008179NHGRI NIH HHS R01 HG008131NHGRI NIH HHS R35 HG011329NHGRI NIH HHS RM1 HG009490NHGRI NIH HHS UM1 HG009435NIAID NIH HHS DP2 AI183504NIAID NIH HHS F32 AI129249NIAID NIH HHS K22 AI153648NIAID NIH HHS R01 AI124693NIAID NIH HHS R01 AI151051NIAID NIH HHS U01 AI142756NIAMS NIH HHS T32 AR007108NINDS NIH HHS R25 NS065745
6 · The paper itself

Abstract

Genome-wide association studies (GWASs) have uncovered hundreds of autoimmune disease-associated loci; however, the causal genetic variants within each locus are mostly unknown. Here, we perform high-throughput allele-specific reporter assays to prioritize disease-associated variants for five autoimmune diseases. By examining variants that both promote allele-specific reporter expression and are located in accessible chromatin, we identify 60 putatively causal variants that enrich for statistically fine-mapped variants by up to 57.8-fold. We introduced the risk allele of a prioritized variant (rs72928038) into a human T cell line and deleted the orthologous sequence in mice, both resulting in reduced BACH2 expression. Naive CD8 T cells from mice containing the deletion had reduced expression of genes that suppress activation and maintain stemness and, upon acute viral infection, displayed greater propensity to become effector T cells. Our results represent an example of an effective approach for prioritizing variants and studying their physiologically relevant effects.

Indexed as

Autoimmune DiseasesGenome-Wide Association StudyAllelesAnimalsGenetic Predisposition to DiseaseMicePolymorphism, Single NucleotideRegulatory Sequences, Nucleic AcidT-Lymphocytes

Identifiers

PMID35513721
PMCPMC9793778

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.